Therapeutic Nanotechnology Applied in Breast and Ovarian Cancers

Therapeutic Nanotechnology Applied in Breast and Ovarian Cancers
shutterstock_185401712A multidisciplinary team at Dartmouth College recently established a method to selectively target breast and ovarian cancer cells using nanoparticles with therapeutic applications. The findings were published in the International Journal of Nanomedicine and the study is entitled “Antibody-mediated targeting of iron oxide nanoparticles to the Folate receptor alpha increases tumor cell association in vitro and in vivo.” Nanotechnology has allowed advances in the detection and treatment of cancer. Iron oxide nanoparticles in particular were one of the first nanomaterials applied in the field of oncology. These iron oxide nanoparticles have magnetic properties and have been applied in medical diagnosis and therapies. To be effective, however, the nanomaterials have to be selectively guided to tumors and cancer cells. “The ultimate utility of anti-cancer nanoparticle technologies will depend in large part on their capacity to selectively home to cancer cells,” explained the study’s lead author Dr. Karl E. Griswold in a news release<
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.